QQQ   354.21 (-1.50%)
AAPL   171.96 (-2.34%)
MSFT   312.14 (-1.70%)
META   298.96 (-0.62%)
GOOGL   128.57 (-1.94%)
AMZN   125.98 (-4.03%)
TSLA   244.12 (-1.16%)
NVDA   419.11 (-0.74%)
NIO   8.40 (+0.60%)
BABA   85.88 (-1.54%)
AMD   95.96 (-1.46%)
T   15.02 (-0.27%)
F   12.44 (-1.11%)
MU   67.94 (-0.93%)
CGC   0.92 (-2.12%)
GE   109.94 (-1.59%)
DIS   80.04 (-1.20%)
AMC   7.92 (-2.82%)
PFE   32.37 (-1.85%)
PYPL   58.93 (+0.12%)
NFLX   379.25 (-1.44%)
QQQ   354.21 (-1.50%)
AAPL   171.96 (-2.34%)
MSFT   312.14 (-1.70%)
META   298.96 (-0.62%)
GOOGL   128.57 (-1.94%)
AMZN   125.98 (-4.03%)
TSLA   244.12 (-1.16%)
NVDA   419.11 (-0.74%)
NIO   8.40 (+0.60%)
BABA   85.88 (-1.54%)
AMD   95.96 (-1.46%)
T   15.02 (-0.27%)
F   12.44 (-1.11%)
MU   67.94 (-0.93%)
CGC   0.92 (-2.12%)
GE   109.94 (-1.59%)
DIS   80.04 (-1.20%)
AMC   7.92 (-2.82%)
PFE   32.37 (-1.85%)
PYPL   58.93 (+0.12%)
NFLX   379.25 (-1.44%)
QQQ   354.21 (-1.50%)
AAPL   171.96 (-2.34%)
MSFT   312.14 (-1.70%)
META   298.96 (-0.62%)
GOOGL   128.57 (-1.94%)
AMZN   125.98 (-4.03%)
TSLA   244.12 (-1.16%)
NVDA   419.11 (-0.74%)
NIO   8.40 (+0.60%)
BABA   85.88 (-1.54%)
AMD   95.96 (-1.46%)
T   15.02 (-0.27%)
F   12.44 (-1.11%)
MU   67.94 (-0.93%)
CGC   0.92 (-2.12%)
GE   109.94 (-1.59%)
DIS   80.04 (-1.20%)
AMC   7.92 (-2.82%)
PFE   32.37 (-1.85%)
PYPL   58.93 (+0.12%)
NFLX   379.25 (-1.44%)
QQQ   354.21 (-1.50%)
AAPL   171.96 (-2.34%)
MSFT   312.14 (-1.70%)
META   298.96 (-0.62%)
GOOGL   128.57 (-1.94%)
AMZN   125.98 (-4.03%)
TSLA   244.12 (-1.16%)
NVDA   419.11 (-0.74%)
NIO   8.40 (+0.60%)
BABA   85.88 (-1.54%)
AMD   95.96 (-1.46%)
T   15.02 (-0.27%)
F   12.44 (-1.11%)
MU   67.94 (-0.93%)
CGC   0.92 (-2.12%)
GE   109.94 (-1.59%)
DIS   80.04 (-1.20%)
AMC   7.92 (-2.82%)
PFE   32.37 (-1.85%)
PYPL   58.93 (+0.12%)
NFLX   379.25 (-1.44%)
NYSE:MMS

Maximus (MMS) Stock Forecast, Price & News

$74.67
-1.68 (-2.20%)
(As of 09/26/2023 ET)
Compare
Today's Range
$74.66
$76.08
50-Day Range
$74.67
$87.74
52-Week Range
$54.46
$89.69
Volume
281,460 shs
Average Volume
337,106 shs
Market Capitalization
$4.54 billion
P/E Ratio
26.67
Dividend Yield
1.50%
Price Target
$101.00

Maximus MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
35.3% Upside
$101.00 Price Target
Short Interest
Healthy
2.03% of Float Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
N/A
News Sentiment
0.28mentions of Maximus in the last 14 days
Based on 4 Articles This Week
Insider Trading
Selling Shares
$348,129 Sold Last Quarter
Proj. Earnings Growth
38.14%
From $3.88 to $5.36 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

3.22 out of 5 stars

Business Services Sector

9th out of 312 stocks

Business Services, Not Elsewhere Classified Industry

5th out of 88 stocks


MMS stock logo

About Maximus (NYSE:MMS) Stock

Maximus, Inc. provides business process services (BPS) to government health and human services programs. It operates through three segments: U.S. Services, U.S. Federal Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments. This segment also provides employment services, such as eligibility support, case management, job-readiness preparation, job search and employer outreach, job retention and career advancement, and educational and training services; technology solutions; system implementation project management services; and specialized consulting services. The U.S. Federal Services segment offers BPS, eligibility and enrollment, outreach, and other services for federal health and human services programs; clinical services; and technology solutions, including application development and modernization services, enterprise business solutions, advanced analytics and emerging technologies, cybersecurity services, and infrastructure and engineering solutions. The Outside the U.S. segment offers BPS solutions for international governments and commercial clients, including health and disability assessments, program administration for employment services, wellbeing solutions, and other job seeker-related services. The company was incorporated in 1975 and is based in Tysons, Virginia.

MMS Price History

MMS Stock News Headlines

Something is Coming for America's Top Stock
This stock has already doubled this year - but it could hurt your portfolio if you hold it much longer. Learn why here.
Maximus Names John Martinez as New General Counsel
Maximus (MMS) Receives a Buy from Stifel Nicolaus
Something is Coming for America's Top Stock
This stock has already doubled this year - but it could hurt your portfolio if you hold it much longer. Learn why here.
Maximus (NYSE:MMS) Is Due To Pay A Dividend Of $0.28
Maximus Reports Fiscal Year 2023 Third Quarter Results
Maximus wins major UK government contract
Maximus (NYSE: MMS)
See More Headlines
Receive MMS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Maximus and its competitors with MarketBeat's FREE daily newsletter.

MMS Company Calendar

Last Earnings
8/02/2023
Ex-Dividend for 8/31 Dividend
8/14/2023
Dividend Payable
8/31/2023
Today
9/26/2023
Fiscal Year End
9/30/2023
Next Earnings (Estimated)
11/20/2023

Industry, Sector and Symbol

Industry
Business services, not elsewhere classified
Sub-Industry
Data Processing & Outsourced Services
CUSIP
57793310
Employees
39,500
Year Founded
1975

Price Target and Rating

Average Stock Price Forecast
$101.00
High Stock Price Forecast
$102.00
Low Stock Price Forecast
$100.00
Forecasted Upside/Downside
+34.3%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Net Income
$203.83 million
Pretax Margin
4.77%

Debt

Sales & Book Value

Annual Sales
$4.63 billion
Cash Flow
$6.51 per share
Book Value
$25.23 per share

Miscellaneous

Free Float
59,994,000
Market Cap
$4.57 billion
Optionable
Optionable
Beta
0.70

Social Links

Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Mr. Bruce L. CaswellMr. Bruce L. Caswell (Age 56)
    Pres, CEO & Director
    Comp: $1.6M
  • Mr. David W. MutrynMr. David W. Mutryn (Age 41)
    CFO & Treasurer
    Comp: $681.77k
  • Mr. David R. FrancisMr. David R. Francis (Age 62)
    Gen. Counsel & Sec.
    Comp: $740.13k
  • Ms. Ilene R. BaylinsonMs. Ilene R. Baylinson (Age 65)
    Gen. Mang. of Health Services U.S.
    Comp: $693.44k
  • Ms. Teresa A. WeipertMs. Teresa A. Weipert (Age 68)
    Gen. Mang. of U.S. Federal Services
    Comp: $925.24k
  • Ms. Theresa D. Golinvaux (Age 48)
    Principal Accounting Officer, Sr. VP & Corp. Controller
  • Ms. Elisabeth Schmidt
    Sr. VP of Technology & Consulting Services
  • Mr. John Lambeth
    Chief Information Officer
  • Ms. Julia Bailey
    Sr. VP of Global Ethics & Compliance
  • Ms. Eileen Cassidy Rivera
    VP of Communications & PR













MMS Stock - Frequently Asked Questions

Should I buy or sell Maximus stock right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Maximus in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" MMS shares.
View MMS analyst ratings
or view top-rated stocks.

What is Maximus' stock price forecast for 2023?

2 analysts have issued twelve-month price objectives for Maximus' shares. Their MMS share price forecasts range from $100.00 to $102.00. On average, they predict the company's share price to reach $101.00 in the next year. This suggests a possible upside of 34.3% from the stock's current price.
View analysts price targets for MMS
or view top-rated stocks among Wall Street analysts.

How have MMS shares performed in 2023?

Maximus' stock was trading at $73.33 at the beginning of the year. Since then, MMS stock has increased by 2.6% and is now trading at $75.22.
View the best growth stocks for 2023 here
.

Are investors shorting Maximus?

Maximus saw a increase in short interest in the month of August. As of August 15th, there was short interest totaling 1,310,000 shares, an increase of 26.0% from the July 31st total of 1,040,000 shares. Based on an average daily volume of 315,900 shares, the days-to-cover ratio is presently 4.1 days. Currently, 2.2% of the company's stock are short sold.
View Maximus' Short Interest
.

When is Maximus' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, November 20th 2023.
View our MMS earnings forecast
.

How were Maximus' earnings last quarter?

Maximus, Inc. (NYSE:MMS) released its earnings results on Wednesday, August, 2nd. The health services provider reported $0.78 EPS for the quarter, missing the consensus estimate of $1.14 by $0.36. The health services provider earned $1.19 billion during the quarter, compared to analyst estimates of $1.20 billion. Maximus had a net margin of 3.56% and a trailing twelve-month return on equity of 15.11%. The firm's quarterly revenue was up 5.6% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.78 EPS.

How often does Maximus pay dividends? What is the dividend yield for Maximus?

Maximus declared a quarterly dividend on Tuesday, July 11th. Stockholders of record on Tuesday, August 15th will be given a dividend of $0.28 per share on Thursday, August 31st. This represents a $1.12 annualized dividend and a yield of 1.49%. The ex-dividend date is Monday, August 14th.
Read our dividend analysis for MMS
.

Is Maximus a good dividend stock?

Maximus (NYSE:MMS) pays an annual dividend of $1.12 per share and currently has a dividend yield of 1.47%. The dividend payout ratio is 40.00%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, MMS will have a dividend payout ratio of 20.90% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for MMS.

What guidance has Maximus issued on next quarter's earnings?

Maximus issued an update on its FY 2023 earnings guidance on Wednesday, August, 2nd. The company provided earnings per share guidance of $3.74-$3.94 for the period, compared to the consensus earnings per share estimate of $3.09. The company issued revenue guidance of $4.88 billion-$4.97 billion, compared to the consensus revenue estimate of $4.95 billion.

What is Bruce Caswell's approval rating as Maximus' CEO?

145 employees have rated Maximus Chief Executive Officer Bruce Caswell on Glassdoor.com. Bruce Caswell has an approval rating of 80% among the company's employees.

What other stocks do shareholders of Maximus own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Maximus investors own include Pfizer (PFE), Lennar (LEN), AbbVie (ABBV), Cisco Systems (CSCO), Kroger (KR), Skyworks Solutions (SWKS), Advanced Micro Devices (AMD), Cerner (CERN), Intel (INTC) and JD.com (JD).

What is Maximus' stock symbol?

Maximus trades on the New York Stock Exchange (NYSE) under the ticker symbol "MMS."

Who are Maximus' major shareholders?

Maximus' stock is owned by many different retail and institutional investors. Top institutional shareholders include BlackRock Inc. (11.60%), Victory Capital Management Inc. (9.62%), Alliancebernstein L.P. (4.85%), Mackenzie Financial Corp (4.35%), State Street Corp (4.19%) and Geode Capital Management LLC (2.18%). Insiders that own company stock include Bruce Caswell, David Francis, David Mutryn, Ilene R Baylinson, Michael J Warren, Michelle F Link, Peter Pond, Raymond B Ruddy, Richard A Montoni, Richard A Montoni, Richard John Nadeau, Teresa Weipert, Thomas D Romeo and Thomas D Romeo.
View institutional ownership trends
.

How do I buy shares of Maximus?

Shares of MMS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Maximus' stock price today?

One share of MMS stock can currently be purchased for approximately $75.22.

How much money does Maximus make?

Maximus (NYSE:MMS) has a market capitalization of $4.57 billion and generates $4.63 billion in revenue each year. The health services provider earns $203.83 million in net income (profit) each year or $2.80 on an earnings per share basis.

How many employees does Maximus have?

The company employs 39,500 workers across the globe.

How can I contact Maximus?

Maximus' mailing address is 1891 METRO CENTER DRIVE, RESTON VA, 20190. The official website for the company is www.maximus.com. The health services provider can be reached via phone at (703) 251-8500, via email at investorrelations@maximus.com, or via fax at 703-251-8240.

This page (NYSE:MMS) was last updated on 9/26/2023 by MarketBeat.com Staff

My Account -